Detalhe da pesquisa
1.
High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients.
Cell
; 186(12): 2705-2718.e17, 2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295406
2.
A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
Cancer
; 128(21): 3850-3859, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041227
3.
Outcomes of Patients with COVID-19 from a Specialized Cancer Care Emergency Room.
Cancer Invest
; 40(1): 17-25, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709102
4.
Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery.
Biol Blood Marrow Transplant
; 26(6): 1071-1076, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32088364
5.
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood Transplantation.
Biol Blood Marrow Transplant
; 26(4): 758-763, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31911259
6.
Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry.
Biol Blood Marrow Transplant
; 26(4): 734-744, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31756534
7.
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(2): 323-332, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31618690
8.
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1526-1535, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30831208
9.
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): 1136-1141, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625387
10.
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(12): 2517-2522, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30055353
11.
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 133-141, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28870777
12.
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Transpl Infect Dis
; 20(4): e12897, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668073
13.
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(1): 67-74, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789361
14.
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies.
Biol Blood Marrow Transplant
; 23(11): 2004-2011, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28733264
15.
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.
Haematologica
; 106(1): 255-258, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079691
16.
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse.
Biol Blood Marrow Transplant
; 21(12): 2106-2114, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26187863
17.
Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation.
Oncologist
; 20(11): 1290-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26446235
18.
Characteristics of Distress and Support Group Participation in Caregivers of Older Allogeneic Hematopoietic Cell Transplantation Patients: A Single Institution Retrospective Review.
J Adv Pract Oncol
; 14(2): 127-137, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37009407
19.
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT.
Blood Adv
; 7(19): 5784-5798, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196646
20.
Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation.
Blood Adv
; 6(22): 5898-5907, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977079